Copyright
©The Author(s) 2025.
World J Gastroenterol. Jun 28, 2025; 31(24): 108234
Published online Jun 28, 2025. doi: 10.3748/wjg.v31.i24.108234
Published online Jun 28, 2025. doi: 10.3748/wjg.v31.i24.108234
Figure 4 Perisurgical colony stimulating factor 1-Fc treatment increased macrophage and proinflammatory gene expression after liver ischemia-reperfusion.
A-L: Whole liver mRNA expression of Adgre1, Cd163, Cd206, Timd4, Mertk, Ccl2, Csf1, Il34, Csf1r, Tgfb1, Il1b and Il6 in the ischemic and oxygenated lobe 48 hours after ischemia-reperfusion; M: Representative immunohistochemistry images of CD163+ cells and necrosis outlined and indicated with ‘N’; N: Percentages of CD163+ cells were quantified, n = 4-6 for all groups and results were analysed with ordinary two-way ANOVA with Tukey’s multiple comparisons for A-L and Mann Whitney test for N. aP < 0.05, bP < 0.01, cP < 0.0001. Data show mean and standard deviation. IL: Ischemic lobe; OL: Oxygenated lobe; CSF: Colony stimulating factor.
- Citation: Schulze S, Keshvari S, Miller GC, Bridle KR, Hume DA, Irvine KM. Perisurgical colony stimulating factor one treatment ameliorates liver ischaemia/reperfusion injury in rats. World J Gastroenterol 2025; 31(24): 108234
- URL: https://www.wjgnet.com/1007-9327/full/v31/i24/108234.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i24.108234